Related Experiment Videos
Brain tumor biology and therapy
1Center for Neuro-Oncology, Western Pennsylvania Hospital, Pittsburgh.
Current Opinion in Neurology and Neurosurgery
|February 1, 1991
Summary
Boron neutron capture therapy for gliomas is gaining traction, contrasting with declining interest in interferon immunotherapy. Research into glioma proliferation pathways offers new therapeutic targets.
Area of Science:
- Neuro-oncology
- Surgical Oncology
- Radiation Oncology
Background:
- Renewed interest in Boron Neutron Capture Therapy (BNCT) for gliomas.
- Decreased enthusiasm for immunotherapies like interferon for brain tumors.
- Advancements in surgical techniques for brain metastases and skull base lesions.
Purpose of the Study:
- To review current trends in neuro-oncology, including emerging and waning therapeutic modalities.
- To highlight the importance of understanding glioma biology for future treatments.
- To discuss the role of surgical intervention in brain metastases and skull base surgery.
Main Methods:
- Literature review of recent advancements in glioma treatment.
- Analysis of therapeutic trends in neuro-oncology.
- Evaluation of surgical outcomes and indications.
Main Results:
- Boron neutron capture therapy shows renewed promise for glioma treatment.
- Interferon-based immunotherapy has seen a decline in enthusiasm.
- Surgical excision is beneficial for solitary brain metastases.
- Technical progress in skull base surgery is significant, but indications for malignant lesions require further definition.
Conclusions:
- The landscape of glioma treatment is evolving, with a resurgence in BNCT and a shift away from certain immunotherapies.
- Understanding glioma proliferative pathways is crucial for developing novel therapeutic strategies.
- Surgical management, particularly for brain metastases and complex skull base cases, continues to advance, necessitating clearer guidelines for malignant conditions.